• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941848250
Medical Device Problem Codes Break (1069); Failure to Advance (2524)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/01/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The 80% stenosed target lesion was located in the not very tortuous left anterior descending artery.A 2.50 x 48mm synergy xd drug-eluting stent (des) was advanced but failed to cross the lesion.The device was removed intact, and upon second attempt to cross the device to the lesion, the device fractured.The device was removed and the procedure was completed a 2.25 x 28 synergy des.There were no patient complications reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: synergy xd mr us 2.50 x 48mm stent delivery system (sds) was returned for analysis.A visual examination of the stent found no issues.There was no sign of damage, stretching or lifting of the stent struts.The stent showed no signs of movement and was set between the proximal and distal markerbands.The stent outer diameter was measured using snap gauge and the result was within max crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of distal tip damage.A visual and tactile examination of the hypotube shaft found multiple kinks and a break 21 cm distal to the strain relief.A visual and tactile examination of the outer and mid-shaft section and a visual examination of the inner lumen found no issues along the shaft polymer extrusion.No other issues were identified during analysis.
 
Event or Problem Description
It was reported that shaft break occurred.The 80% stenosed target lesion was located in the not very tortuous left anterior descending artery.A 2.50 x 48mm synergy xd drug-eluting stent (des) was advanced but failed to cross the lesion.The device was removed intact, and upon second attempt to cross the device to the lesion, the device fractured.The device was removed and the procedure was completed a 2.25 x 28 synergy des.There were no patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15266103
Report Number2134265-2022-08384
Device Sequence Number6494390
Product Code NIQ
UDI-Device Identifier08714729985204
UDI-Public08714729985204
Combination Product (Y/N)Y
Initial Reporter StateMO
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/08/2024
Device Model NumberH7493941848250
Device Lot Number0029049659
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/01/2022
Supplement Date Received by Manufacturer09/06/2022
Initial Report FDA Received Date08/22/2022
Supplement Report FDA Received Date09/28/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/09/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age78 YR
Patient SexFemale
-
-